Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma, Hardback Book

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma Hardback

Edited by Michael J. Murphy

Part of the Current Clinical Pathology series

Hardback

Description

This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development.

A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined.

As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease.

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.

Information

Save 14%

£201.00

£172.65

Item not Available
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Current Clinical Pathology series  |  View all